90 related articles for article (PubMed ID: 18991484)
1. Minimal engraftment of human CD34+ cells mobilized from healthy donors in the infarcted heart of athymic nude rats.
Sondergaard CS; Bonde J; Dagnaes-Hansen F; Nielsen JM; Zachar V; Holm M; Hokland P; Pedersen L
Stem Cells Dev; 2009; 18(6):845-56. PubMed ID: 18991484
[TBL] [Abstract][Full Text] [Related]
2. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
Hogan CJ; Shpall EJ; McNiece I; Keller G
Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction.
Armiñán A; Gandía C; García-Verdugo JM; Lledó E; Trigueros C; Ruiz-Saurí A; Miñana MD; Solves P; Payá R; Montero JA; Sepúlveda P
J Am Coll Cardiol; 2010 May; 55(20):2244-53. PubMed ID: 20466205
[TBL] [Abstract][Full Text] [Related]
4. 111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model.
Brenner W; Aicher A; Eckey T; Massoudi S; Zuhayra M; Koehl U; Heeschen C; Kampen WU; Zeiher AM; Dimmeler S; Henze E
J Nucl Med; 2004 Mar; 45(3):512-8. PubMed ID: 15001696
[TBL] [Abstract][Full Text] [Related]
5. Age-dependent availability and functionality of bone marrow stem cells in an experimental model of acute and chronic myocardial infarction.
Ayala-Lugo A; Tavares AM; Paz AH; Alegretti A; Miquelito L; Bock H; Giugliani R; Clausell N; Cirne-Lima E; Rohde LE
Cell Transplant; 2011; 20(3):407-19. PubMed ID: 21535915
[TBL] [Abstract][Full Text] [Related]
6. Mobilization and engraftment of peripheral blood stem cells in healthy related donors >55 years old.
Motlló C; Sancho JM; Grífols JR; Juncà J; Morgades M; Ester A; Rodríguez I; Vives S; Batlle M; Guardia R; Ferrà C; Gallardo D; Millá F; Feliu E; Ribera JM
Cytotherapy; 2014 Mar; 16(3):406-11. PubMed ID: 24176544
[TBL] [Abstract][Full Text] [Related]
7. Xenotransplantation of immunodeficient mice with mobilized human blood CD34+ cells provides an in vivo model for human megakaryocytopoiesis and platelet production.
Perez LE; Rinder HM; Wang C; Tracey JB; Maun N; Krause DS
Blood; 2001 Mar; 97(6):1635-43. PubMed ID: 11238102
[TBL] [Abstract][Full Text] [Related]
8. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.
de Bont ES; Guikema JE; Scherpen F; Meeuwsen T; Kamps WA; Vellenga E; Bos NA
Cancer Res; 2001 Oct; 61(20):7654-9. PubMed ID: 11606408
[TBL] [Abstract][Full Text] [Related]
9. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
10. Intrahepatic transplantation of CD34+ cord blood stem cells into newborn and adult NOD/SCID mice induce differential organ engraftment.
Wulf-Goldenberg A; Keil M; Fichtner I; Eckert K
Tissue Cell; 2012 Apr; 44(2):80-6. PubMed ID: 22197619
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of Immortalized CD34+ and CD34- Adipose-Derived Stem Cells Improve Cardiac Function and Mitigate Systemic Pro-Inflammatory Responses.
Kim JH; Choi SC; Park CY; Park JH; Choi JH; Joo HJ; Hong SJ; Lim DS
PLoS One; 2016; 11(2):e0147853. PubMed ID: 26840069
[TBL] [Abstract][Full Text] [Related]
12. CXCR4-transgene expression significantly improves marrow engraftment of cultured hematopoietic stem cells.
Brenner S; Whiting-Theobald N; Kawai T; Linton GF; Rudikoff AG; Choi U; Ryser MF; Murphy PM; Sechler JM; Malech HL
Stem Cells; 2004; 22(7):1128-33. PubMed ID: 15579633
[TBL] [Abstract][Full Text] [Related]
13. Effects of MSC coadministration and route of delivery on cord blood hematopoietic stem cell engraftment.
Carrancio S; Romo C; Ramos T; Lopez-Holgado N; Muntion S; Prins HJ; Martens AC; Briñón JG; San Miguel JF; Del Cañizo MC; Sanchez-Guijo F
Cell Transplant; 2013; 22(7):1171-83. PubMed ID: 23031585
[TBL] [Abstract][Full Text] [Related]
14. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells.
Kawamoto A; Iwasaki H; Kusano K; Murayama T; Oyamada A; Silver M; Hulbert C; Gavin M; Hanley A; Ma H; Kearney M; Zak V; Asahara T; Losordo DW
Circulation; 2006 Nov; 114(20):2163-9. PubMed ID: 17075009
[TBL] [Abstract][Full Text] [Related]
15. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors.
Pilarski LM; Belch AR
Clin Cancer Res; 2002 Oct; 8(10):3198-204. PubMed ID: 12374689
[TBL] [Abstract][Full Text] [Related]
16. Determination of engraftment potential of human cord blood stem-progenitor cells as a function of donor cell dosage and gestational age in the NOD/SCID mouse model.
Ural SH; Sammel MD; Blakemore KJ
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):990-4. PubMed ID: 16157099
[TBL] [Abstract][Full Text] [Related]
17. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit.
Nauta AJ; Kruisselbrink AB; Lurvink E; Mulder A; Claas FH; Noort WA; Willemze R; Fibbe WE
Exp Hematol; 2005 Oct; 33(10):1249-56. PubMed ID: 16219548
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction.
Turan RG; Brehm M; Koestering M; Tobias Z; Bartsch T; Steiner S; Picard F; Ebner P; Schannwell CM; Strauer BE
Eur J Clin Invest; 2007 Nov; 37(11):842-51. PubMed ID: 17973780
[TBL] [Abstract][Full Text] [Related]
19. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].
Sawada H; Wake A; Yamasaki Y; Izumi Y
Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350
[TBL] [Abstract][Full Text] [Related]
20. Direct cardiac injection of G-CSF mobilized bone-marrow stem-cells improves ventricular function in old myocardial infarction.
Archundia A; Aceves JL; López-Hernández M; Alvarado M; Rodriguez E; Díaz Quiroz G; Páez A; Rojas FM; Montaño LF
Life Sci; 2005 Dec; 78(3):279-83. PubMed ID: 16183081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
